Pharmacokinetic Studies of Tacrolimus in Transplant Patients
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The study is designed to compare the steady-state pharmacokinetics of Prograf (Brand) and the
two most disparate generic formulations (Generic Hi and Generic Lo) in a fully replicated,
3-way cross-over study in stable kidney (n=36) and liver transplant (n=36) subjects.
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Collaborators:
Children's Hospital Medical Center, Cincinnati University of Colorado, Denver